Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

401
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
401
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

175
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
175
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

367
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
367
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

199
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
199
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

301
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
301
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

223
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
223

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of the authentication and authorization processes for the iAgree portal, a platform for patient-controlled data sharing across health systems.

JAMIA open·2026
Same author

Foundation Model-Guided Synthetic EHR Release: Performance Enhancement with Privacy Preservation.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
Same author

Large Models for Small Tables: Adapting Tabular Foundation Models to EHR Data.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
Same author

Memorization in large language models in medicine prevalence characteristics and implications.

Nature communications·2026
Same author

Privacy-enhancing sequential learning under heterogeneous selection bias in multi-site electronic health records data.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

Exploring patient motivations and preferences for medical data sharing with researchers: a simulation study using the iAgree platform.

Journal of the American Medical Informatics Association : JAMIA·2026

Related Experiment Video

Updated: Sep 3, 2025

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

47.8K

Simplified Machine Learning Models Can Accurately Identify High-Need High-Cost Patients With Inflammatory Bowel

Nghia H Nguyen1, Sagar Patel1, Jason Gabunilas1

  • 1Division of Gastroenterology, Department of Medicine, University of California San, Diego, La Jolla, California, USA.

Clinical and Translational Gastroenterology
|July 29, 2022
PubMed
Summary

Machine learning models accurately identify high-need, high-cost (HNHC) inflammatory bowel disease (IBD) patients at risk for costly hospitalizations. These advanced algorithms improve upon traditional methods for predicting healthcare utilization in IBD.

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
08:37

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

16.8K

Related Experiment Videos

Last Updated: Sep 3, 2025

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

47.8K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
08:37

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

16.8K

Area of Science:

  • Health Informatics
  • Machine Learning in Healthcare
  • Inflammatory Bowel Disease (IBD) Research

Background:

  • Hospitalizations are the main driver of healthcare costs and morbidity in inflammatory bowel disease (IBD).
  • Existing prediction models struggle to identify patients at high risk for unplanned healthcare utilization.
  • Identifying high-need and high-cost (HNHC) patients can potentially reduce healthcare utilization and costs.

Purpose of the Study:

  • To develop and compare machine learning algorithms for predicting HNHC status in hospitalized IBD patients.
  • To assess the performance of tree-based algorithms (decision tree classifier, XGBoost) against traditional logistic regression.

Main Methods:

  • Retrospective cohort study using the Nationwide Readmissions Database (2013 and 2017).
  • Adult patients hospitalized with IBD were analyzed to identify HNHC patients (highest decile of hospital days).
  • Two tree-based algorithms and logistic regression were built and validated to predict HNHC risk.

Main Results:

  • Identified 4,717 HNHC patients out of 47,402 hospitalized IBD patients.
  • Tree-based models demonstrated superior predictive performance: Decision Tree AUC 0.78, XGBoost AUC 0.79 (derivation) and 0.78, 0.75 (validation).
  • Traditional logistic regression showed significantly lower performance (AUC 0.55-0.56).

Conclusions:

  • Simplified tree-based machine learning algorithms can accurately predict hospitalized IBD patients at risk of becoming HNHC.
  • These models utilize administrative claims data, offering a practical approach for risk stratification.
  • Accurate prediction of HNHC patients can inform targeted interventions to reduce healthcare utilization and costs in IBD.